title: Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4.
abstract: Insulin stimulates adipose cells both to secrete proteins and to translocate the GLUT4 glucose transporter from an intracellular compartment to the plasma membrane. We demonstrate that whereas insulin stimulation of 3T3-L1 adipocytes has no effect on secretion of the alpha3 chain of type VI collagen, secretion of the protein hormone adipocyte complement related protein of 30 kD (ACRP30) is markedly enhanced. Like GLUT4, regulated exocytosis of ACRP30 appears to require phosphatidylinositol-3-kinase activity, since insulin-stimulated ACRP30 secretion is blocked by pharmacologic inhibitors of this enzyme. Thus, 3T3-L1 adipocytes possess a regulated secretory compartment containing ACRP30. Whether GLUT4 recycles to such a compartment has been controversial. We present deconvolution immunofluorescence microscopy data demonstrating that the subcellular distributions of ACRP30 and GLUT4 are distinct and nonoverlapping; in contrast, those of GLUT4 and the transferrin receptor overlap. Together with supporting evidence that GLUT4 does not recycle to a secretory compartment via the trans-Golgi network, we conclude that there are at least two compartments that undergo insulin-stimulated exocytosis in 3T3-L1 adipocytes: one for ACRP30 secretion and one for GLUT4 translocation.
authors.affiliation: Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142-1479, USA.
authors.forename: J S
authors.initials: JS
authors.lastname: Bogan
authors.forename: H F
authors.initials: HF
authors.lastname: Lodish
mesh_terms: D016475:3T3 Cells; D033982:Adaptor Protein Complex gamma Subunits; D017667:Adipocytes / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D052242:Adiponectin; D000818:Animals; D001798:Blood Proteins / Q000032:analysis* / Q000378:metabolism; D020756:Coatomer Protein; D003094:Collagen / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000737:chemistry / Q000378:metabolism; D005089:Exocytosis / Q000187:drug effects*; D005455:Fluorescent Antibody Technique; D051275:Glucose Transporter Type 4; D006056:Golgi Apparatus / Q000737:chemistry; D007328:Insulin / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins / Q000032:analysis; D008565:Membrane Proteins / Q000032:analysis; D051379:Mice; D008869:Microtubule-Associated Proteins / Q000032:analysis; D009004:Monosaccharide Transport Proteins / Q000032:analysis* / Q000378:metabolism; D009124:Muscle Proteins; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011506:Proteins; D011990:Receptors, Transferrin / Q000032:analysis
chemical_list: D033982:Adaptor Protein Complex gamma Subunits; D052242:Adiponectin; D001798:Blood Proteins; D020756:Coatomer Protein; D003094:Collagen; D051275:Glucose Transporter Type 4; D007328:Insulin; D036341:Intercellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D008869:Microtubule-Associated Proteins; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011506:Proteins; D011990:Receptors, Transferrin; C495693:Slc2a4 protein, mouse; C053387:endoplasmin